New Innovation & Information on Pharmaceutical Industry in Japan

• PHARMACEUTICAL

  31 5月

  Wakayama Medical University publised “Cancer Vaccine Therapy Using Carcinoembryonic Antigen – expressing Dendritic Cells generated from Induced Pluripotent Stem Cells” in Nature.

  Wakayama Medical University publised "Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells"

  Read More >>

• PHARMACEUTICAL

  31 5月

  Chugai Starts Activities towards Commercialization of Foundation Medicine’s Products in Japan — Chugai Enters a License Agreement with Roche and Submits for Regulatory Approval of “FoundationOne CDx™”

  They filed for the regulatory approval to

  Read More >>

• MULTIVALUE

  31 5月

  Information of Berkeley Lights

  Huge opportunity for innovation and collaboration in cell based R&D, antimab-commercialization cost. Please find their homepage: Home Berkeley Lights is enabling pr

  Read More >>

• PHARMACEUTICALS

  28 6月

  Multiplex gene panel examination for personalized medicine” carried out using the joint development system

  The National Cancer Research Center announced the press release. For details, please see the following URL: https://www.ncc.go.jp/jp/information/pr_release/2018/0403/i

  Read More >>

• PHARMACEUTICALS

  28 6月

  Multiplex Gene Panel Testing to Advancing Personalized Medicine using the system developed jointly by the National Cancer

  Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine

  On April 1, 2018, Multiplex Gene Panel Testing to

  Read More >>

• PHARMACEUTICALS

  28 6月

  Ino Pharmaceutical Co., Ltd. signed a drug discovery alliance agreement with Merus of the Netherlands

  It seems to aim for the development of bispecific antibodies as post-opsvo. For details, refer to the following URL. https://www.ono.co.jp/jpnw/PDF/n18_0314.pdf Mar

  Read More >>

• PHARMACEUTICALS

  28 6月

  National Cancer Research Center Central Hospital Genetic testing to comprehensively examine cancer-related genes

  The use of reagent "NCC onco panel" developed based on the characteristics of Japanese seems to be a feature of profiling. For details, please see the following URL: h

  Read More >>

• PHARMACEUTICALS

  27 6月

  Prediction of the effectiveness of Sysmex immunosuppressant inhibitor, aiming for practical use

  The original press release is at the following URL. Please refer. http://www.sysmex.co.jp/corporate/news/2018/180404.html Conclusion of a re-license patent relat

  Read More >>